Published in Plast Reconstr Surg on August 01, 2011
Volumetric Study of Fat Resorption After Breast Lipofilling (Lipofilling) | NCT03016663
A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med (2012) 1.07
The role of adipose-derived stem cells in breast cancer progression and metastasis. Stem Cells Int (2015) 0.90
On the safety of autologous fat grafting for breast reconstruction. Plast Reconstr Surg (2012) 0.86
Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Stem Cells Int (2016) 0.84
Breast reconstruction de novo by water-jet assisted autologous fat grafting--a retrospective study. Ger Med Sci (2013) 0.81
Discussion: The oncologic outcome and immediate surgical complications of lipofilling in breast cancer patients: a multicenter study--Milan-Paris-Lyon experience of 646 lipofilling procedures. Plast Reconstr Surg (2011) 0.81
Update on breast reconstruction techniques and indications. World J Surg (2012) 0.79
The Safety, Effectiveness, and Efficiency of Autologous Fat Grafting in Breast Surgery. Plast Reconstr Surg Glob Open (2016) 0.79
Fat Grafting with Tissue Liquefaction Technology as an Adjunct to Breast Reconstruction. Aesthetic Plast Surg (2016) 0.79
Lipofilling in breast cancer surgery. Gland Surg (2013) 0.76
Autologous Fat Transplantation to the Reconstructed Breast Does not Hinder Assessment of Mammography and Ultrasound: A Cohort Study. World J Surg (2016) 0.76
Sequelae of fat grafting postmastectomy: an algorithm for management of fat necrosis. Eplasty (2012) 0.75
Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study. Plast Reconstr Surg (2017) 0.75
Fast and simple fat grafting of the breast. Gland Surg (2015) 0.75
Autologous bone-marrow-derived-mononuclear-cells-enriched fat transplantation in breast augmentation: evaluation of clinical outcomes and aesthetic results in a 30-year-old female. Case Rep Surg (2013) 0.75
Autologous fat transfer to the subcutaneous tissue in the context of breast reconstructive procedures. Postepy Dermatol Alergol (2016) 0.75
Latissimus dorsi flap invasion by ductal breast carcinoma after lipofilling. Plast Reconstr Surg Glob Open (2013) 0.75
Evaluation of Lipofilling Safety in Elderly Patients with Breast Cancer. Plast Reconstr Surg Glob Open (2015) 0.75
Shaping of the Unaffected Breast with Brava-Assisted Autologous Fat Grafting to Obtain Symmetry after Breast Reconstruction. Aesthet Surg J (2015) 0.75
Reduction and Mastopexy Techniques for Optimal Results in Oncoplastic Breast Reconstruction. Semin Plast Surg (2015) 0.75
Lipofilling effects after breast cancer surgery in post-radiation patients: an analysis of results and algorithm proposal. Eur J Plast Surg (2017) 0.75
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med (2003) 11.93
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol (2013) 6.79
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol (2013) 4.21
Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg (2010) 3.61
Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer. J Clin Oncol (2009) 2.98
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Clin Cancer Res (2004) 2.46
Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol (2006) 2.36
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. J Natl Cancer Inst (2003) 2.25
Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial. J Clin Oncol (2012) 2.22
Consensus conference on breast conservation. J Am Coll Surg (2006) 2.17
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features. Breast Cancer Res Treat (2010) 1.97
Poly implant prothèse asymmetrical anatomical breast implants: a product recall study. Plast Reconstr Surg (2015) 1.96
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat (2011) 1.89
Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence? Breast (2011) 1.80
Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer (2005) 1.73
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel. Cancer Chemother Pharmacol (2007) 1.66
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg (2003) 1.63
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat (2008) 1.62
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat (2010) 1.59
Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg (2006) 1.56
Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"? Breast (2013) 1.51
Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer (2004) 1.48
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J (2009) 1.48
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol (2005) 1.47
Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann Surg (2005) 1.47
Macroscopic quality control improves the reliability of blue dye-only sentinel lymph node biopsy in breast cancer. Ann Surg Oncol (2003) 1.43
A subfascial variant of the deep inferior epigastric artery demonstrated by preoperative multidetector computed tomographic angiography: a case report. Microsurgery (2010) 1.40
Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol (2007) 1.40
Appropriate use of magnetic resonance imaging and ultrasound to detect early silicone gel breast implant rupture in postmastectomy reconstruction. Plast Reconstr Surg (2014) 1.39
Fat Grafting after Invasive Breast Cancer: A Matched Case-Control Study. Plast Reconstr Surg (2017) 1.38
The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progression. Cancer Res (2011) 1.37
Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol (2005) 1.36
The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells (2010) 1.34
Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol (2013) 1.30
Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer (2009) 1.28
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy. Breast Cancer Res Treat (2008) 1.24
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg (2008) 1.20
The "perfusion map" of the unipedicled TRAM flap to reduce postoperative partial necrosis. Ann Plast Surg (2004) 1.17
Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol (2002) 1.17
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat (2011) 1.14
Nipple-sparing mastectomy--is it worth the risk? Nat Rev Clin Oncol (2011) 1.14
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Breast Cancer Res Treat (2005) 1.12
Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat (2012) 1.11
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution. Cancer (2004) 1.11
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature. Breast Cancer Res Treat (2006) 1.09
Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol (2008) 1.07
Adipose tissue cells, lipotransfer and cancer: a challenge for scientists, oncologists and surgeons. Biochim Biophys Acta (2012) 1.06
Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome. Clin Breast Cancer (2012) 1.05
Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer. Cancer Res (2013) 1.05
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. Breast (2006) 1.04
Conservative mastectomy: extending the idea of breast conservation. Lancet Oncol (2012) 1.03
Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol (2008) 1.02
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer. Eur J Cancer (2010) 1.00
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy. Ann Surg Oncol (2012) 1.00
Sentinel node biopsy in patients with previous breast aesthetic surgery. Ann Surg Oncol (2009) 0.99
Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial. Cancer Prev Res (Phila) (2011) 0.99
Percutaneous fasciotomies and fat grafting: indications for breast surgery. Aesthet Surg J (2013) 0.99
Results of chest wall resection for recurrent or locally advanced breast malignancies. Breast (2007) 0.97
Chapter 11: Tissue engineering of peripheral nerves. Int Rev Neurobiol (2009) 0.96
Breast-conserving surgery in 201 very young patients (<35 years). Breast (2009) 0.95
Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys (2008) 0.95
Extramammary recurrence of DCIS after total mastectomy: an iatrogenic displacement following needling procedures? Breast J (2005) 0.95
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17. Eur J Cancer (2007) 0.95
Metronomic chemotherapy combined with bevacizumab and erlotinib in patients with metastatic HER2-negative breast cancer: clinical and biological activity. Clin Breast Cancer (2012) 0.94
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? Ann Surg Oncol (2009) 0.94
Radiographic findings after breast augmentation by autologous fat transfer. Plast Reconstr Surg (2011) 0.94
Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer (2011) 0.93
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer. Clin Breast Cancer (2010) 0.93
Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol (2005) 0.93
The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results. Breast Cancer Res Treat (2005) 0.93
Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch Surg (2002) 0.92
In vivo dosimetry using radiochromic films during intraoperative electron beam radiation therapy in early-stage breast cancer. Radiother Oncol (2003) 0.91
Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol (2005) 0.91
Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging (2010) 0.89
Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat (2008) 0.89
Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis. Ann Surg Oncol (2012) 0.89
Sarcoma of the breast: outcome and reconstructive options. Clin Breast Cancer (2012) 0.89
Efficacy of leukocyte- and platelet-rich fibrin in wound healing: a randomized controlled clinical trial. Plast Reconstr Surg (2012) 0.89
Sentinel node biopsy in male breast cancer. Nucl Med Commun (2004) 0.88
Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases. Oncologist (2010) 0.88
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy. Breast Cancer Res Treat (2010) 0.87
Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users. Ann Surg Oncol (2002) 0.87
Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy. Cancer (2006) 0.86
Conservative treatment of breast cancer: its evolution. Breast Cancer Res Treat (2005) 0.86
Sarcoid-like reaction in breast cancer: a long-term follow-up series of eight patients. Surg Today (2011) 0.86
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features. Anticancer Drugs (2009) 0.86
Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol (2007) 0.85
Abdominal complications and sequelae after breast reconstruction with pedicled TRAM flap: is there still an indication for pedicled TRAM in the year 2003? Plast Reconstr Surg (2003) 0.85
Breast fat grafting (lipomodelling) after extended latissimus dorsi flap breast reconstruction: a preliminary report of 200 consecutive cases. J Plast Reconstr Aesthet Surg (2010) 0.85